证券代码：600887 证券简称：伊利股份 公告编号：临 2025-017 内蒙古伊利实业集团股份有限公司 第十一届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 内蒙古伊利实业集团股份有限公司（简称"公司"）第十一届董事会 第六次会议于2025年4月28日（星期一）上午10:00在公司五楼会议室以 现场和通讯相结合的方式召开。本次会议通知于2025年4月18日以邮件方 式发出，会议应当出席的董事十名，实际出席会议的董事十名。会议由 董事长潘刚先生主持，监事会成员和董事会秘书列席了会议。会议符合 《公司法》《公司章程》的有关规定，合法有效。 二、董事会会议审议情况 会议审议并通过了以下议案，形成如下决议： （一）审议并通过了《公司 2024 年年度报告及摘要》（具体内容详 见上海证券交易所网站 www.sse.com.cn）； 本议案已经董事会审计委员会审议通过，并同意提交董事会审议。 表决结果：同意10票，反对0票，弃权0票。 本议案需提交股东大会审议。 （二）审议并通过了《 ...

证券代码：600887 证券简称：伊利股份 公告编号：临 2025-019 内蒙古伊利实业集团股份有限公司 关于 2024 年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： A 股每股派发现金红利人民币 1.22 元（含税）。 公司未触及《上海证券交易所股票上市规则》第 9.8.1 条第一 款第（八）项规定的可能被实施其他风险警示的情形。 一、利润分配预案内容 （一）利润分配方案的具体内容 截至 2024 年 12 月 31 日，经信永中和会计师事务所（特殊普通合伙） 审计，公司母公司报表期末未分配利润为人民币 27,552,877,909.81 元。 经董事会决议，公司以实施 2024 年度权益分派股权登记日登记的总股本 扣除公司回购专户股份数后的股本为基数分配利润，本次利润分配方案 如下： 公司拟向全体股东每股派发现金红利 1.22 元（含税），截至 2025 年 4 月 8 日，公司总股本 6,365,900,705 股，扣除公司回购专户股份 32,859,361 股，以此计算合计拟 ...

证券代码：600887 证券简称：伊利股份 公告编号：临 2025-024 内蒙古伊利实业集团股份有限公司 关于发行境内外债务融资工具的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为满足内蒙古伊利实业集团股份有限公司（简称"公司"）业务发 展的资金需求，公司于 2024 年 4 月 28 日召开第十一届董事会第三次会 议和第十一届监事会第三次会议、2024 年 5 月 20 日召开 2023 年年度股 东大会，审议通过了《公司关于申请注册发行境内债务融资工具的议案》， 同意公司境内发行多品种债务融资工具（DFI）项下所有产品的余额合计 不超过 400 亿元人民币。具体内容详见公司在上海证券交易所网站披露 的《内蒙古伊利实业集团股份有限公司关于申请注册发行境内债务融资 工具的公告》（公告编号：临 2024-029）。 为进一步满足公司境内业务资金需求，降低融资成本，公司拟向股 东大会申请增加 50 亿元多品种债务融资工具（DFI）发行规模，本次增 加发行规模后，公司发行多品种债务融资工具（DFI）项下所有产品的余 额合 ...

索引 内部控制审计报告 页码 1–2 信永中和会计师事务所| 北京市东城区朝阳门北大街 8 号富华大厦 A 座 9 内蒙古伊利实业集团股份有限公司 2024 年度 内部控制审计报告 QIE Block A Fill 内部控制审计报告 XYZH/2025XAAA4B0264 内蒙古伊利实业集团股份有限公司 内蒙古伊利实业集团股份有限公司董事会: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审计 了内蒙古伊利实业集团股份有限公司(以下简称伊利集团)2024年 12 月 31 日财务报告 内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部控制评价指 引》的规定,建立健全和有效实施内部控制,并评价其有效性是伊利集团董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表审计意 见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于情况的 变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的 ...

内蒙古伊利实业集团股份有限公司 2024 年度 审计报告 | 索引 | | 页码 | | --- | --- | --- | | 审计报告 | | 1-5 | | 公司财务报表 | | | | — | 合并资产负债表 | 1-2 | | — | 母公司资产负债表 | 3-4 | | — | 合并利润表 | 5 | | — | 母公司利润表 | 6 | | — | 合并现金流量表 | 7 | | — | 母公司现金流量表 | 8 | | — | 合并股东权益变动表 | 9-10 | | — | 母公司股东权益变动表 | 11-12 | | — | 财务报表附注 | 13-160 | 审计报告 XYZH/2025XAAA4B0186 内蒙古伊利实业集团股份有限公司 内蒙古伊利实业集团股份有限公司全体股东： 一、 审计意见 我们审计了内蒙古伊利实业集团股份有限公司（以下简称伊利集团）财务报表，包 括 2024 年 12 月 31 日的合并及母公司资产负债表，2024 年度的合并及母公司利润表、 合并及母公司现金流量表、合并及母公司股东权益变动表，以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业 ...

中信证券股份有限公司 关于内蒙古伊利实业集团股份有限公司 部分募投项目结项、节余募集资金使用及延期的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为内蒙古 伊利实业集团股份有限公司（以下简称"伊利股份"、"公司"或"伊利集团"） 2021 年非公开发行 A 股股票持续督导阶段的保荐人，根据《证券发行上市保荐 业务管理办法》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等有 关规定，就伊利股份 2021 年非公开发行募集资金投资项目结项、节余募集资金 使用及延期的事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准内蒙古伊利实业集团股份有限公司非 公开发行股票的批复》（证监许可[2021]3196 号）核准，公司于 2021 年 12 月 9 日完成向 22 名特定投资者以非公开发行股票的方式发行人民币普通股（A 股） 317,953,285股，发行价格为37.89元/股，募集资金总额为人民币12,047,249,968.65 元，扣除不含税发行费用人民币 6,28 ...

Core Insights - The company achieved a total revenue of 115.78 billion yuan in 2024, maintaining its position as the leading dairy company in Asia [1] - The net profit, excluding goodwill impairment, was 11.539 billion yuan, representing a year-on-year growth of 12.2% [1] - The net cash flow from operating activities reached 21.74 billion yuan, an increase of 18.86% compared to the previous year [1] Industry Overview - The dairy consumption demand faced some suppression due to economic slowdown, low consumer confidence, and short-term imbalances in raw milk supply and demand [1] - Despite these challenges, dairy products are considered essential consumer goods, indicating a degree of inelastic demand [1] - The industry is expected to experience healthier and more sustainable development as raw milk supply and demand return to balance [1] Company Operations - The company is engaged in the production and sales of various dairy products and health drinks, including liquid milk, milk beverages, milk powder, yogurt, frozen drinks, cheese, and packaged drinking water [1] - The company holds the leading market share in liquid dairy products and adult milk powder, as well as maintaining its position as the top player in the ice cream market for 30 consecutive years [1] Innovation and R&D - The company adheres to the principle of "Yili means quality," focusing on consumer-centric approaches, accelerating technological and product innovation, and optimizing its business portfolio [2] - In 2024, the company's R&D expenditure was 870 million yuan, the highest among listed companies in the dairy industry [2] - The company continuously launches new products based on consumer demand, with new product revenue accounting for 15.1% of total revenue [5] Technological Advancements - The company initiated an AI application platform for breast milk research to enhance formula development efficiency and accelerate product iteration [5] - The deployment of generative AI capabilities includes the creation of the dairy industry's first large model product, YILI-GPT, and the establishment of a new intelligent platform, YILI-Agent, to support intelligent operations and innovation breakthroughs [5] Profit Distribution - The company announced a profit distribution plan, proposing a cash dividend of 1.22 yuan per share (including tax), with a total proposed cash dividend amounting to 7.726 billion yuan, representing 91.4% of the net profit for the period [5]

Financial Performance - The company's operating revenue for Q1 2025 was CNY 32,938,299,808.43, representing a year-on-year increase of 1.46% compared to CNY 32,462,896,350.54 in the same period last year[4]. - The net profit attributable to shareholders decreased by 17.71% to CNY 4,874,104,242.93 from CNY 5,922,814,507.71 in the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 24.19% to CNY 4,629,303,049.44 from CNY 3,727,609,925.90 year-on-year[4]. - The basic and diluted earnings per share were both CNY 0.77, down 17.20% from CNY 0.93 in the previous year[4]. - The weighted average return on equity decreased by 1.78 percentage points to 8.74% from 10.52% year-on-year[4]. - The company reported a net profit margin of approximately 17.39% for Q1 2025, down from 21.23% in Q1 2024[18]. - The total comprehensive income for Q1 2025 was CNY 5.22 billion, compared to CNY 5.56 billion in Q1 2024[19]. - Net profit for Q1 2025 was CNY 4.95 billion, a decrease of 17% compared to CNY 5.95 billion in Q1 2024[19]. - The company's operating profit for Q1 2025 was ¥7.69 billion, down from ¥8.26 billion in Q1 2024, a decrease of about 7.0%[30]. Cash Flow - The net cash flow from operating activities decreased significantly by 58.19% to CNY 948,079,882.53 from CNY 2,267,600,204.82 in the same period last year[4]. - The decline in net cash flow from operating activities was primarily due to a decrease in advance payments from distributors, leading to reduced cash receipts from sales[8]. - Cash flow from operating activities for Q1 2025 was CNY 948 million, a decline of 58% from CNY 2.27 billion in Q1 2024[23]. - The total cash inflow from operating activities in Q1 2025 was ¥25,685,722,671.82, compared to ¥29,043,491,510.57 in Q1 2024, showing a decline[32]. - The cash outflow for purchasing goods and services in Q1 2025 was ¥20,628,737,292.77, down from ¥28,656,761,235.64 in Q1 2024[32]. - The net cash flow from financing activities in Q1 2025 was ¥1,121,546,197.36, down from ¥9,943,111,365.70 in Q1 2024, reflecting a decrease in financing activities[32]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 154,847,139,953.19, an increase of 0.73% from CNY 153,718,003,927.97 at the end of the previous year[4]. - Current assets totaled ¥70.63 billion, up from ¥66.62 billion at the end of 2024, reflecting a growth of 3.02%[14]. - Current liabilities decreased to ¥88.18 billion from ¥89.92 billion, a reduction of 1.94%[15]. - Non-current liabilities decreased significantly from ¥6.79 billion to ¥4.35 billion, a decline of 35.98%[15]. - The company's total current liabilities amounted to ¥81.71 billion as of March 31, 2025, compared to ¥80.34 billion at the end of 2024, showing a slight increase of 1.7%[28]. - The total equity attributable to shareholders increased to ¥58.34 billion from ¥53.18 billion, a growth of 9.99%[15]. Research and Development - Research and development expenses rose to ¥191.33 million, an increase of 31.67% compared to ¥145.36 million in Q1 2024[18]. - Research and development expenses for Q1 2025 were ¥172.15 million, up from ¥122.85 million in Q1 2024, reflecting a growth of approximately 40.2%[30]. Investment Activities - Cash flow from investing activities in Q1 2025 was negative CNY 1.61 billion, slightly worse than negative CNY 1.59 billion in Q1 2024[24]. - The company received CNY 20.59 billion from investment recoveries in Q1 2025, a significant increase from CNY 633 million in Q1 2024[24]. - The total cash inflow from investment activities in Q1 2025 was ¥23,929,852,825.34, compared to ¥7,771,491,596.20 in Q1 2024, indicating a substantial increase[32]. - The net cash flow from investment activities in Q1 2025 was ¥2,341,007,257.30, compared to ¥5,551,524,409.52 in Q1 2024, showing a decline[32]. Tax and Expenses - The company reported a tax expense of CNY 808 million in Q1 2025, down from CNY 968 million in Q1 2024[19].

Financial Performance - In 2024, the company's operating revenue was CNY 115.39 billion, a decrease of 8.24% compared to CNY 125.76 billion in 2023[21]. - The net profit attributable to shareholders was CNY 8.45 billion, down 18.94% from CNY 10.43 billion in the previous year[21]. - The net profit after deducting non-recurring gains and losses was CNY 6.01 billion, a decline of 40.04% compared to CNY 10.03 billion in 2023[21]. - Basic earnings per share decreased by 18.90% to CNY 1.33 in 2024 compared to CNY 1.64 in 2023[22]. - Diluted earnings per share also fell by 18.90% to CNY 1.33 in 2024 from CNY 1.64 in 2023[22]. - The weighted average return on equity decreased by 4.39 percentage points to 15.81% in 2024 from 20.20% in 2023[22]. - The company achieved total revenue of 115.78 billion CNY and a net profit of 8.464 billion CNY during the reporting period[47]. - The company's operating revenue for the period was approximately CNY 115.39 billion, a decrease of 8.24% compared to the previous year[60]. - The company's operating costs decreased by 10.01% to approximately CNY 76.30 billion, primarily due to reduced sales volume and lower raw material prices[60]. Cash Flow and Assets - The net cash flow from operating activities increased by 18.86% to CNY 21.74 billion, up from CNY 18.29 billion in 2023[21]. - The total assets at the end of 2024 were CNY 153.72 billion, reflecting a 1.38% increase from CNY 151.62 billion at the end of 2023[21]. - The net cash flow from operating activities in Q3 2024 was CNY 8.54 billion, while Q4 was CNY 7.87 billion[26]. - The company's total R&D investment amounted to ¥869,976,531.80, representing 0.75% of its operating revenue[70]. - The total assets include cash and cash equivalents of ¥25,404,255,558.60, which is 16.53% of total assets, down 41.43% from the previous year[78]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 1.22 per share, totaling CNY 7.73 billion, which represents 91.40% of the net profit for 2024[5]. - The cumulative cash dividend amount over the last three accounting years is 21,986,737,202.88 RMB, with a cash dividend ratio of 243.57% based on the average annual net profit of 9,437,488,376.97 RMB[162]. Market Position and Sales - The company maintains its leadership position in the dairy industry, ranking first in China, first in Asia, and among the top five globally[35]. - The retail market share for liquid dairy products remains the highest in the segment, with infant formula market share at 17.3%, up 1.1 percentage points year-on-year, and adult milk powder at 24%, up 0.8 percentage points year-on-year[36]. - The liquid milk business generated revenue of 75.003 billion CNY, maintaining the industry's highest retail market share[47]. - The infant formula and dairy products segment reported revenue of 29.675 billion CNY, a year-on-year increase of 7.53%[49]. - The company's e-commerce channel for infant formula saw a revenue growth of 50.8%, with an overall market share of 17.3%[51]. Innovation and Product Development - New product revenue accounts for 15.1% of total revenue, driven by innovations such as "Anmuxi" probiotic yogurt and "Golden Crown" organic infant formula[39]. - The company upgraded its research institute to a global maternal and infant nutrition research center, enhancing product capabilities in infant nutrition[54]. - The company launched several new products, including "Anmuxi" ambient probiotic yogurt, which contributed to a 1.4 percentage point increase in ambient yogurt market share[47]. - The company has made significant breakthroughs in the extraction and application of lactoferrin, enhancing the functionality and added value of dairy products[72]. Sustainability and Environmental Initiatives - The company is focused on sustainable development and innovation, with key technologies recognized by industry awards, enhancing its competitive edge[44]. - The company invested a total of 205 million yuan in environmental protection in 2024, focusing on wastewater treatment facility upgrades and online monitoring equipment[180]. - The company launched the "Zero Carbon Future Plan" and roadmap, upgrading its carbon reduction targets for 2024 and achieving significant progress in greenhouse gas emission management and carbon neutrality certification for four key products and five factories[191]. - The company has achieved zero sludge generation in 40 wastewater treatment systems, an increase of 3 systems from 2023[187]. - The company has established 34 subsidiaries recognized as "water-saving enterprises," an increase of 2 from the end of 2023[189]. Governance and Management - The company has a clear governance structure with independent directors constituting over one-third of the board[128]. - The company has established a performance evaluation and incentive mechanism for senior management to ensure efficiency and fairness[132]. - The company strictly adheres to information disclosure regulations, ensuring that all shareholders have equal access to information[132]. - The company has implemented a strict insider information management system to maintain fairness in information disclosure[133]. - The company’s board of directors includes members with extensive experience in various sectors, enhancing governance and strategic decision-making[138]. Employee Engagement and Development - The company has a total of 63,414 employees, with 26,244 in the parent company and 37,170 in major subsidiaries[151]. - The company has established two digital learning platforms, "Yi Qi Xue" and "Yi Qi Ying," to enhance employee capabilities and support long-term development[154]. - The company has maintained a high level of employee engagement and satisfaction, leading to recognition as a top employer in the industry[153]. - The company has a comprehensive compensation management system that aligns value return with organizational and individual performance, including various incentive awards[153]. Risks and Challenges - The company faces potential risks including supply chain disruptions due to geopolitical factors and financial risks related to international operations[124]. - The company is actively working on compliance strategies to address the discharge issues reported across its facilities[177][178].

内蒙古伊利实业集团股份有限公司 2024 年度独立董事述职报告（蔡元明） 作为内蒙古伊利实业集团股份有限公司（简称"公司"）的独立董 事，根据《中华人民共和国公司法》（简称"《公司法》"）《上市公 司独立董事管理办法》《上海证券交易所上市公司自律监管指引第1号— —规范运作》等法律法规、规范性文件及《公司章程》《公司独立董事 制度》的有关规定，2024年，本人严格遵照相关要求认真履行职责，积 极出席相关会议，认真审议各项议案，促进了公司的规范运作，切实维 护了公司和股东特别是中小股东的合法权益。同时，公司对本人的工作 也给予了积极有效的支持和配合，未有妨碍独立董事独立性的情况发生。 现将2024年度履行独立董事职责的情况汇报如下： 一、独立董事的基本情况 公司第十一届董事会共有四名独立董事，占董事会人数三分之一以 上，符合相关法律法规中关于独立董事人数比例和专业配置要求。 （一）个人工作履历、专业背景以及兼职情况 蔡元明先生：工商管理硕士，历任阿尔斯通电力集团全球副总裁、西 安陕鼓动力股份有限公司副总经理兼董事会秘书。现任公司独立董事。 （二）是否存在影响独立性的情况说明 作为公司的独立董事，本人符合《上市公 ...